Hospital
Osceolasc LLC
Osceolasc LLC was paid $5.62M by Medicaid between Jan 2018 and Dec 2024, across 142 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoOSCEOLASC LLC
SAINT CLOUD, FL 34769
SAINT CLOUD, FL 34769
33aNPI1164478442assigned 05/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.62M
24GClaims271,799
24DCodes billed142
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#78 of 163
Median peer was paid$4.77M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,987 | $230K | |
| 2019 | 64,462 | $901K | |
| 2020 | 46,853 | $608K | |
| 2021 | 41,779 | $843K | |
| 2022 | 41,336 | $1.16M | |
| 2023 | 37,563 | $1.30M | |
| 2024incomplete | 18,819 | $578K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 15,736 | 14,272 | $1.26M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 13,771 | 11,938 | $1.16M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 6,982 | 5,997 | $563K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.1% | 2,775 | 2,488 | $513K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.2% | 5,760 | 4,846 | $348K |
| 36415 | Collection of venous blood by venipuncture | 4.1% | 19,073 | 14,189 | $232K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3.8% | 2,441 | 2,050 | $214K |
| 80053 | Comprehensive metabolic panel | 2.8% | 14,841 | 11,920 | $155K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 927 | 776 | $109K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 3,186 | 2,602 | $105K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.6% | 535 | 468 | $89K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.5% | 1,376 | 1,251 | $82K |
130 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 1,203 | $68K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,090 | $54K |
| 84703 | <1% | 5,791 | $54K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,964 | $42K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,803 | $39K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,188 | $31K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 577 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,502 | $23K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,263 | $22K |
| 87070 | <1% | 1,665 | $20K | |
| G0378 | Hospital observation service, per hour | <1% | 2,865 | $20K |
| 84484 | <1% | 6,788 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,940 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,612 | $19K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 5,840 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,328 | $16K |
| 82962 | <1% | 3,097 | $15K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 753 | $15K |
| 86900 | <1% | 401 | $14K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 277 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,239 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,654 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,526 | $11K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 808 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,152 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,368 | $9K |
| 81003 | <1% | 2,281 | $9K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,145 | $9K |
| 73562 | <1% | 349 | $8K | |
| 73610 | <1% | 331 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,438 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,801 | $8K |
| 85027 | <1% | 8,236 | $7K | |
| 81001 | <1% | 8,805 | $7K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 425 | $7K |
| 76830 | Ultrasound, transvaginal | <1% | 630 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 734 | $5K |
| 73630 | <1% | 350 | $5K | |
| 72131 | <1% | 597 | $5K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 25 | $5K |
| 80061 | Lipid panel | <1% | 1,219 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,085 | $4K |
| 87631 | <1% | 838 | $4K | |
| 83735 | <1% | 6,219 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 20 | $4K |
| 73130 | <1% | 157 | $4K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 405 | $4K |
| 73110 | <1% | 185 | $3K | |
| 87420 | <1% | 265 | $3K | |
| 85610 | <1% | 1,436 | $3K | |
| 73030 | <1% | 161 | $3K | |
| 76801 | <1% | 196 | $2K | |
| 74018 | <1% | 212 | $2K | |
| 87430 | <1% | 1,325 | $2K | |
| 83880 | <1% | 412 | $2K | |
| 84100 | <1% | 189 | $2K | |
| 87641 | <1% | 465 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,111 | $2K |
| 87081 | <1% | 351 | $2K | |
| 99499 | <1% | 14 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 168 | $1K |
| 84702 | <1% | 381 | $1K | |
| 73080 | <1% | 28 | $1K | |
| 73090 | <1% | 14 | $1K | |
| 96376 | <1% | 778 | $1K | |
| 93017 | <1% | 80 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,766 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,345 | $977.33 |
| 87186 | <1% | 925 | $972.19 | |
| 87088 | <1% | 349 | $914.45 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,472 | $896.73 |
| 87040 | <1% | 440 | $842.52 | |
| 85378 | <1% | 808 | $809.84 | |
| 85730 | <1% | 857 | $792.34 | |
| 83690 | <1% | 4,543 | $781.63 | |
| 82550 | <1% | 1,043 | $702.62 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 112 | $674.53 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 146 | $644.68 |
| 82553 | <1% | 770 | $591.73 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,039 | $554.81 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,287 | $528.23 |
| 93971 | <1% | 48 | $483.48 | |
| 87210 | <1% | 1,370 | $468.58 | |
| 80305 | <1% | 150 | $416.97 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,136 | $411.13 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,986 | $385.22 |
| 70486 | <1% | 29 | $307.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 761 | $289.95 |
| 83605 | <1% | 521 | $245.35 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 247 | $222.73 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,406 | $205.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,631 | $181.71 |
| 87205 | <1% | 166 | $170.43 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 138 | $165.03 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 399 | $156.61 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 768 | $137.30 |
| 84439 | <1% | 549 | $133.06 | |
| 99152 | <1% | 75 | $116.51 | |
| 94664 | <1% | 79 | $111.02 | |
| 85379 | <1% | 387 | $97.97 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 754 | $95.63 |
| 72100 | <1% | 29 | $73.02 | |
| 86901 | <1% | 385 | $52.65 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,657 | $52.59 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 244 | $39.37 |
| 87147 | <1% | 35 | $37.91 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 499 | $22.02 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 91 | $15.09 |
| 86886 | <1% | 19 | $8.34 | |
| 81025 | <1% | 760 | $6.88 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 380 | $0.00 |
| 94760 | 0% | 53 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 223 | $0.00 |
| 80047 | 0% | 24 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 48 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 101 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 40 | $0.00 |
| 86850 | 0% | 42 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 12 | $0.00 |
| 85652 | 0% | 13 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 136 | $0.00 |
| 85014 | 0% | 24 | $0.00 | |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 17 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 197 | $0.00 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 16 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 152 | $0.00 |
| 01999 | 0% | 89 | $0.00 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 20 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 21 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.